(Press-News.org) Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples. Compared to its diagnostic predecessors, LUCAS creates 500-fold stronger and 8-fold longer-lasting bioluminescence signals, overcoming longstanding challenges faced by point-of-care diagnostics. Their study published today in Nature Biomedical Engineering.
“Developing effective diagnostics is incredibly challenging, especially when you think about the size of infectious disease particles and the complicated biological fluids we’re attempting to identify them in. Finding an HIV particle in a human blood sample is like finding an ice cube in a jelly-filled Olympic swimming pool while blindfolded,” said senior author Hadi Shafiee, PhD, a faculty member in the Division of Engineering in Medicine and Renal Division of Medicine at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system. “With its novel enzyme cascade approach, LUCAS marks a substantial leap forward for sensing viruses in these complex biological samples.”
Point-of-care diagnostics have become essential tools in many households, as people measure their blood sugar, take pregnancy tests, and even conduct their own COVID-19 assays. These diagnostics, which allow people to forgo tedious, expensive laboratory testing, are important for disease detection, treatment, and monitoring. Yet current diagnostics can fall short, with faults like inaccuracy and poor sensitivity. Bioluminescence has the potential to alleviate common shortcomings experienced by other methods, like background noise, false positives, photobleaching and phototoxicity.
Bioluminescence utilizes the same natural enzyme that makes fireflies glow to light up biological samples for imaging. The enzyme, luciferase, is added to a sample to find and flag viral particles. Then, luciferin molecules are introduced to that sample, prompting a luciferase reaction that creates a burst of light. But this reaction produces a light signal that is both weak and short-lived.
Shafiee and team developed a unique enzyme signal cascade to strengthen and prolong bioluminescence signals. They introduce another enzyme to the equation, called beta-galactosidase, that sticks to luciferin and releases it continuously, rather than allowing luciferin to float freely in the sample for one-and-done reactions. This extra step means more luciferin, more luciferase reactions, and more bioluminescence. In fact, this step enabled LUCAS to be 515 times more bioluminescent than non-LUCAS systems, and LUCAS signals maintained 96% strength after an hour.
To evaluate LUCAS’ efficacy, the team used 177 viral-spiked patient samples and 130 viral-spiked serum samples infected with either SARS-CoV-2, HIV, HBV, or HCV. SARS-CoV-2 patient samples were collected via nasopharyngeal swab, while HIV, HBV, and HCV samples were collected via blood draw. LUCAS provided diagnostic answers within 23 minutes and with an average accuracy across all pathogens of over 94%.
The researchers designed LUCAS to be both portable and easy to use so that it can be an option for high- and low-resource point-of-care environments. As a next step, the team will be testing LUCAS’ efficacy in other biological fluids and whether the method can identify more than one pathogen at once. Shafiee also notes that biomarker identification for many diseases, including Alzheimer’s, is a rapidly evolving space—so having a tool like LUCAS ready to go as new biomarkers emerge could prove impactful in years to come.
“We always want to detect infection and disease as early as possible, as that can make all the difference when it comes to care and long-term outcomes,” said first author Sungwan Kim, PhD, a postdoctoral researcher in Shafiee’s lab at the Brigham. “With our focus on developing diagnostic tools that are sensitive, accurate, and accessible, we want to make early detection easier than it has ever been and push personalized care into a new era.”
Authorship: In addition to Shafiee and Kim, Mass General Brigham authors include Giwon Cho, Jaebaek Lee, Khushi Doshi, Supriya Gharpure, Jisan Kim, Juyong Gwak, Joseph M. Hardie, Manoj K. Kanakasabapathy, Hemanth Kandula, Prudhvi Thirumalaraju, Younseong Song, Hui Chen, Daniel R. Kuritzkes, Jonathan Z. Li, and Athe M. Tsibris.
Disclosures: Kim and Shafiee have filed a patent on the reported technology through Brigham and Women's Hospital.
Funding: This work was partially supported by the National Institutes of Health under award numbers (R01EB033866, R01AI138800, R01AI138800-05S1, U54HL119145, R33AI140489, and (R61AI140489).
Paper cited: Kim S et al. “Ultrasensitive and long-lasting bioluminescence immunoassay for point-of-care viral antigen detection” Nature Biomedical Engineering DOI: 10.1038/s41551-025-01405-9
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
As the digital world demands greater data storage and faster access times, magnetic memory technologies have emerged as a promising frontier. However, conventional magnetic memory devices have an inherent limitation: They use electric currents to generate the magnetic fields necessary to reverse their stored magnetization, leading to energy losses in the form of heat. This inefficiency has pushed researchers to explore approaches that could further reduce power consumption in magnetic memories while maintaining or even enhancing their performance.
Multiferroic materials, ...
This compelling book sheds light on one of the most defining yet often overlooked forces in Japanese society: dōchō atusryoku (conformity pressure). Far beyond a matter of individual psychology, this book argues that conformity acts as an important force in shaping politics, governance, and the legal system in Japan. It is a force that binds people together, enforces unspoken rules, and even fills the gaps where laws or clear leadership are absent.
At the heart of this analysis is the concept of “sekken”—the collective social ...
The water we use every day is purified in wastewater treatment plants and discharged into rivers, and in recent years, the reuse of treated water for domestic and industrial use has been expanding to solve the water shortage problem. The purification process removes various harmful substances, including phosphorus, which causes green algae, and disinfects microorganisms such as total coliform. Phosphorus is an essential component of domestic and industrial waste, including fertilizers, detergents, and animal manure, but when it remains in the water, it causes algae blooms in rivers and lakes.
A research team led by Dr. Jae-Woo Choi and Dr. Kyungjin Cho of the Center ...
New research finds that self-employed women have fewer risk factors for cardiovascular disease (CVD) compared to non-self-employed women, suggesting that the work environment may play a role in the development of risk factors that can lead to heart attacks.
While the findings also showed some positive associations between health outcomes and self-employment among white men, the researchers found women had the most favorable CVD risk profile associated with being self-employed, possibly because they are more likely than men to experience stress and time demands related to balancing responsibilities across work and home.
Self-employed men ...
Journals from BMJ Group Press Release:
Embargoed 23:30 hours UK (BST) time Thursday 29 May 2025
Please click on links for full articles and contact authors direct for further comment - details can be found under Notes for Editors. Please remember to credit the relevant journal - this assures your audience it is from a reputable source.
Headlines:
US general military service may lower, rather than heighten, depression risk
Around 1 in 7 US adults who smoke may have some degree of disability
BMJ MILITARY HEALTH
Externally ...
A new study has found that depression is linked to an increased risk of dementia in both mid and later life.
The new research, which is published in eClinicalMedicine, was led by Jacob Brain and Maha Alshahrani from the Institute of Mental Health and School of Medicine at the University of Nottingham, University of Adelaide and the Dementia Centre of Excellence at Curtin University in Australia.
Mr Brain said: "Our study shows that depression is linked to an increased risk of dementia in both midlife ...
A new study published in The Lancet Child & Adolescent Health journal suggests that parental or caregiver intuition may outperform some traditional early warning systems in identifying children at risk of deterioration. The new analysis found that caregiver concern for worsening condition of paediatric patients was strongly associated with critical illness in pediatric patients admitted to the hospital, even after accounting for abnormal vital signs (abnormal heart rate or abnormal respiratory rate).
In high-income countries critical illness in children is rare, and often ...
Around 1 in 7 of US adults who currently smoke may have some degree of disability, suggests the first study of its kind published online in the journal Tobacco Control.
And the prevalence of disability and/or some degree of functional difficulty is twice as high among those who continue to puff away as it is among those who have never smoked, the data analysis indicates.
All in all, the figures suggest that 40% of the estimated 25 million adults who currently smoke experience some level of functional difficulty, ...
In 2024, Brazil celebrated the 20th anniversary of the Bolsa Família Programme (BFP), one of the world’s largest conditional cash transfer initiatives. A new study published in The Lancet Public Health shows that the BFP has prevented more than 8.2 million hospitalisations and 713,083 deaths in Brazil between 2004 and 2019. In addition, it is estimated that an additional 683,721 deaths could be prevented if the programme's coverage is expanded by 2030.
These programmes provide cash transfers to low-income families, often with school-age children, provided they meet certain conditions, such as ensuring school attendance and up-to-date vaccinations. ...
Open water swimming can be strangely claustrophobic. Immerse your face in cloudy water and your view might dwindle to a few centimetres. Yet, harbour seals (Phoca vitulina) manage to negotiate the turbid coastal waters in which they reside with ease, detecting their surroundings through various senses, including their dextrous whiskers. But Frederike Hanke from University of Rostock, Germany, wondered whether the resourceful creatures may also to use their vision to determine which direction they are manoeuvring in, despite the opaque view. ‘We wanted to know whether harbour seals can determine their heading from ...
